Skip to content

Combined Application of Qing Yi Dao Xie Tang and Huang Xiao Plaster for the Treatment of Mild Acute Pancreatitis as Fu Shi Re Jie Syndrome: A Clinical Observation

Combined Application of Qing Yi Dao Xie Tang and Huang Xiao Plaster for the Treatment of Mild Acute Pancreatitis as Fu Shi Re Jie Syndrome: A Clinical Observation

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078065
Enrollment
Unknown
Registered
2023-11-28
Start date
2023-11-28
Completion date
Unknown
Last updated
2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pancreatitis

Interventions

Experimental Group 1:Adding oral administration of the Chinese herbal medicine Qing Yi Dao Xie Tang to the treatment protocol in the control group.
Experimental Group 2:In experimental group 1, Huang Xiao Plaster was added to the treatment protocol.
Control Group:Application of acid-suppressing and pancreatic secretion inhibiting medication.

Sponsors

Changsha Hospital of Traditional Chinese Medicine (Changsha Eighth Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with acute pancreatitis. 2.Patients aged 18 and above. 3.Patients meeting specific clinical criteria for the study, such as pain, pancreatic function abnormalities, etc. 4.Patients willing to participate in the study and who have signed informed consent forms..

Exclusion criteria

Exclusion criteria: 1.Patients with other severe conditions such as heart disease, liver disease, kidney disease, etc. (including those with malignant tumors or chronic liver, kidney, or heart failure). 2.Patients with other pancreatic diseases, such as pancreatic cancer or pancreatic cysts. 3.Pregnant or lactating women. 4.Patients with a history of long-term medication use or drug allergies. 5.Patients unable to comply with the study protocol during the research process.

Design outcomes

Primary

MeasureTime frame
lipase;TCM Inspection;Pulse diagnosis;progression of severe acute pancreatitis;

Secondary

MeasureTime frame
Complete blood cell count;CRP;Serum calcium;

Countries

China

Contacts

Public ContactXuhui Li

Changsha Hospital of Traditional Chinese Medicine (Changsha Eighth Hospital)

1464469430@qq.com+86 156 4985 8578

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026